Patents by Inventor Céline Ducournau

Céline Ducournau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
    Publication number: 20200330568
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Applicants: UNIVERSITÉ DE TOURS, KYMERIS THERAPEUTICS INC., Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
    Inventors: Isabelle DIMIER-POISSON, Marie-Noëlle MEVELEC, Céline DUCOURNAU, Nathalie MOIRE, Richard MCCRAE
  • for use in treating cancer and infectious diseases
    Patent number: 10736947
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: August 11, 2020
    Assignees: UNIVERSITÉ DE TOURS, KYMERIS THERAPUETICS INC., Institut national de recherche pour l' agriculture, l' alimentation et l'environneement
    Inventors: Isabelle Dimier-Poisson, Marie-Noëlle Mevelec, Céline Ducournau, Nathalie Moire, Richard McCrae
  • NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
    Publication number: 20180353580
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Application
    Filed: June 8, 2018
    Publication date: December 13, 2018
    Inventors: Isabelle DIMIER-POISSON, Marie-Noëlle MEVELEC, Céline DUCOURNAU, Nathalie MOIRE, Richard MCCRAE
  • Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
    Patent number: 9731005
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment of a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid, without said cationic-polysaccharide core being surrounded by any phospholipidic layer, and at least an antigen obtained from said pathogen.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: August 15, 2017
    Assignees: UNIVERSITE DE DROIT ET DE SANTE DE LILLE II, UNIVERSITE DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau
  • PHARMACEUTICAL COMPOSITION COMPRISING A SOLID NANOPARTICLE AND AT LEAST AN ANTIGEN FOR THE TREATMENT AGAINST AN INTRACELLULAR PATHOGENIC AGENT
    Publication number: 20150238598
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment in a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid without being surrounded by any phospholipidic layer and at least an antigen obtained from said pathogen.
    Type: Application
    Filed: September 13, 2013
    Publication date: August 27, 2015
    Applicants: UNIVERSITÉ DE DROIT ET DE SANTÉ DE LILLE II, UNIVERSITÉ DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau